Network·Hedge Fund
📍 DOYLESTOWN, PA
SEC CRD #802-130242
Hatch Biofund About Investment Focus People Partners News Contact Hatch Biofund is a life sciences venture capital firm headquartered in the Philadelphia region, one of the fastest-growing biotech hubs in the world. At Hatch, we provide early-stage capital to promising life science companies, along with access to deep industry expertise and physical platforms to help them realize their missions. We put collaboration at the center of everything we do, with a core mission of delivering key support to exceptional entrepreneurs working on life-changing scientific solutions. 1. Transitive verb: to bring into being by incubation 2. Transitive verb: to draw with precise, closely spaced lines 3. Noun: an exit path or opening DEFINITION Hatch /hæt/ HATCH BIOFUND Enabling Life-Changing Discoveries Hatch Biofund invests exclusively in private companies developing therapeutics and vaccines for human use. INVESTMENT FOCUS We invest in all treatment modalities, from small molecules to cell and gene therapy, but are partial to capital efficiency, clear development pathways, and experimental medicines that promise to bring great value to society. We take an active role in all of our investments and leverage our partner relationships for the benefit of our portfolio companies. INVESTMENT FOCUS About Investment Focus People Partners News Contact PEOPLE Lorenzo Pellegrini, Ph.D. Managing Partner View More > Louis P. Kassa III, MPA Founder and Advisor View More > Timothy M. Block, Ph.D. Founder
Satellite Office
MANAGING PARTNER
📞 (215) 589-6310
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$20M–$20M
Location
DOYLESTOWN, PA
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.